Search

everythinglearnresearchcommunity

for

Search:↓

Urinary PSA could be an early marker for enlarged prostate.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

The Epilight Hair Removal System is effective for temporary hair removal with few side effects, but more research is needed to confirm its safety and long-term results.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

Lichen sclerosus et atrophicus is generally not considered precancerous, but there are exceptions.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.

The technique successfully reconstructed a functional neo-vagina with 100% survival and patency, but lacked mucus secretion.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Older men with postoperative urinary retention are more likely to need future bladder procedures.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Prostatitis is a common male condition with various causes and treatments, often involving antibiotics and lifestyle changes.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

Finasteride may cause floppy-iris syndrome during cataract surgery, so check patients' medical history.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

Wnt4 is essential for heart repair and could be a target for heart disease treatment.